Terns Pharmaceuticals, Inc. (TERN)
NASDAQ·Healthcare·Biotechnology
$52.97
+0.04%
Mkt Cap $4.76B
Analyst Ratings
Buy
19
Hold
4
Sell
0
Price Target (33 analysts)
$55.56
Range $35.00 – $70.00
Implied Upside
+4.9%
Consensus $55.56 vs current $52.97
NASDAQ·Healthcare·Biotechnology
$52.97
+0.04%
Mkt Cap $4.76B
Buy
19
Hold
4
Sell
0
Price Target (33 analysts)
$55.56
Range $35.00 – $70.00
+4.9%
Consensus $55.56 vs current $52.97